赛拓动力学 CYTK
$53.69 −$1.86 (-3.35%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $54.02 +0.61%
开盘$55.70
昨收$55.55
当日区间$53.55 – $56.51
成交量2.56M
市值$7.48B
市盈率（TTM）–
股息率–
CYTK 相关新闻
匹配 Cytokinetics 或代码 CYTK 的头条新闻，按最新排序。
- Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112
- Cytokinetics(CYTK.US) Officer Sells US$7.34 Million in Common Stock
- Form 144 | Cytokinetics(CYTK.US) Insider Proposes to Sell 7.09 Million in Common Stocks
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Cytokinetics (CYTK) and Biohaven Ltd. (BHVN)
- RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112
- A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $85 to $140
- A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $100 to $140
- BofA Securities Maintains Cytokinetics(CYTK.US) With Hold Rating, Maintains Target Price $85
- Barclays Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $110
- J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating
- Barclays Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $110 正面
- Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Announces Target Price $112
- J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $103
- J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $103 正面
- Needham Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $102
暂无评论——快来第一个聊聊 CYTK。
登录后参与讨论。